On the afternoon of February 2, HTA and GE Healthcare held a signing ceremony with the theme of "Working together to Create a New chapter of win-win cooperation" in Beijing, bringing together forces and innovative cooperation to sign an agreement on cooperation in the field of nuclear medicine diagnostic drugs, and working together to promote the high-quality development of the global nuclear drug industry.
China Tongfu Party Secretary Zhang Junqi, GE Healthcare Global Executive Vice President, GE Healthcare China President and CEO Zhang Yihao, GE Healthcare Global Director of nuclear pharmaceutical Products Nguyen, Quang Trung attended and witnessed the signing ceremony. Kevin O 'Neill, global Vice President and CEO of GE Healthcare Diagnostics, Casey Julia, General manager of GE Healthcare Diagnostics, and Zhao Jing, General manager of Atomtech, and Xiao Yindi, Vice president and General manager of GE Healthcare China Diagnostics, signed the cooperation agreement on behalf of the two parties.
Zhang Yihao said that this cooperation between the two sides is the best practice of strengthening cooperation between Chinese and international enterprises, building a health bridge through medical treatment to promote the community of human destiny, and is another important milestone in GE Healthcare's China strategy of "comprehensive domestic, borderless innovation, and win-win cooperation". It is believed that with the efforts of both sides, this innovative cooperation will accelerate the entry of new neurological drugs into the clinic, allow nuclear medicine technology to assist in the early diagnosis and treatment of serious diseases, benefit patients, explore the path of national health modernization, and promote the accessibility of precision medicine and high-quality medical resources.
Xiao Yindi said that the cooperation between GE Healthcare and HTA is an important milestone and an important step in the localization process of GE Healthcare's high-end nuclear drugs, and the two sides have the same vision to explore mutually beneficial cooperation, work together to promote the localization of international high-end nuclear drugs, and contribute to the realization of the "Healthy China 2030" strategy.
Zhang Junqi said that this cooperation is the first cooperation between China Tongfu, HTA and GE Healthcare in the field of nuclear medicine, and also the further deepening of the comprehensive cooperation between China Tongfu and GE Healthcare, which is of great significance to promote the innovative development and high-quality development of global high-end nuclear medicine and nuclear medical imaging equipment. Based on the growing demand of China's nuclear drug market, HTA and GE Medical are highly aligned in the direction of industrial development and business layout, and the in-depth strategic cooperation reached by the two sides is conducive to promoting the innovation of the cooperation mode between state-owned enterprises and international leading medical equipment enterprises, and helping the rapid development of a new generation of radiopharmaceuticals in China.
As a leading domestic nuclear technology application enterprise integrating research and development, production, sales and service, China Tongfu will take this cooperation as a starting point, actively respond to the group's "cooperation has my endeavor in the nuclear" initiative, with the idea of "one game of chess", strengthen industrial synergy, deepen the upstream and downstream synergy chain of nuclear technology application industry, give full play to the joint advantages of strong and strong, and innovate cooperation models. Integrate high-quality resources, work together with GE Healthcare to focus on the precision medical science and technology innovation of early detection of serious diseases and integration of diagnosis and treatment, and work together to draw the development blueprint of domestic high-end nuclear drugs and nuclear medical imaging equipment to benefit global human public health.
GE Healthcare China Chief Talent Officer, GE Healthcare China financial business and treasurer and business development director, GE Healthcare China Diagnostic medicine business Nuclear Medicine Product manager, HTA Co., Ltd. and nuclear energy related leaders and departments attended the signing activity.
